WuXi XDC Cayman targets $470.5M IPO in Hong Kong By Investing.com
Investing.com | Editor Pollock Mondal Published Nov 07, 2023 04:59AM ET WuXi XDC Cayman, a specialist in antibody-drug conjugates backed by WuXi Biologics ...
Read moreInvesting.com | Editor Pollock Mondal Published Nov 07, 2023 04:59AM ET WuXi XDC Cayman, a specialist in antibody-drug conjugates backed by WuXi Biologics ...
Read moreWuXi XDC Cayman, a specialist in antibody-drug conjugates backed by WuXi Biologics (HK:) and Wuxi AppTec, is targeting a HK$3.68 ...
Read moreWe publish a comprehensive news feed covering all news relevant to the crypto user, covering main industry news, politics and regulation as well as consumer-level “news you can use” (practical stuff), including handy DIY tips, links to useful tools, unbiased reviews and opinions revolving around cryptocurrency. Simple logic and real-world examples are preferred before technical jargon and personal rants.